GL1X · GenesisL1 explorer

MolNFT v1 · #191358 · protein

Crystal structure of SARS-cov-2 main protease (mpro) M165Y mutant in complex with nirmatrelvir

8DCZ · 3C-like proteinase NSP5: “Crystal structure of SARS-cov-2 main protease (mpro) M165Y mutant in complex with nirmatrelvir”. X-ray diffraction, 1 ligand (4WI), 7 pockets (best druggability 0.76). MolNFT v1 #191358 on GenesisL1: 3D…

PDB
8DCZ
Type
protein
Length
610 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTD1
Ligands
4WI
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase NSP5 (EC 3.4.22.69)protein30526% helix, 29% strandP0DTD1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18490.760.7963empty
23500.560.7548empty
32300.550.78264WI
42020.500.76244WI
51420.420.7524empty

Interfaces

1 interface between chains.

  • A–B · 1559 Ų buried · 39 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 8DCZ · Crystal Structure of SARS-CoV-2 Main Protease (Mpro) M165Y Mutant in Complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.